Dihydromyricetin enhances herceptin sensitivity to breast cancer cells through inhibiting the insulin-like growth factor 1 receptor downstream phosphatidylinositol 3-kinase/protein kinase B signaling pathway

ZHANG Mingliang; PAN Chengwu; WANG Gang; JIN Gongsheng; QIAN Jun

doi:10.3969/j.issn.2095-3097.2017.06.006

Home>Articles>Dihydromyricetin enhances herceptin sensitivity to breast cancer cells through inhibiting the insulin-like growth factor 1 receptor downstream phosphatidylinositol 3-kinase/protein kinase B signaling pathway

DOI: 10.3969/j.issn.2095-3097.2017.06.006

Dihydromyricetin enhances herceptin sensitivity to breast cancer cells through inhibiting the insulin-like growth factor 1 receptor downstream phosphatidylinositol 3-kinase/protein kinase B signaling pathway

ZHANG Mingliang

PAN Chengwu

WANG Gang

JIN Gongsheng

QIAN Jun

Machine-generated Keywords：

Publication Date：2017-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 340-344,349 )

Translational Medicine Journal

ISTIC

ISSN：2095-3097

Year, Vol.(Issue)：2017,6(6)